
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC
("Pennpetro" or the "Company")
Company Accepts a Convertible Loan Note Facility for
Introduction
Pennpetro (LSE: PPP) is pleased to announce that it has agreed to enter into a Convertible Loan Note Facility with
Upon Closing, the Company will be able to draw down
The Company previously entered into a
"We are delighted that GEM has continued to support and share our vision for the Company. The new Convertible Loan Note Facility, coupled with the reinstatement of the previous Share Subscription Facility will ensure the Company is able to access the funds it requires for the foreseeable future", commented
The Convertible Loan Note Facility
The term of the Facility is three years, with a zero coupon.
GEM may convert the Initial Tranche into shares of the Company at the lesser of
At maturity the Convertible Loan Notes convert automatically at the lesser of the relevant Fixed Conversion Price or the Floating Conversion Price.
Concurrently with entering into the CLNF, GEM is being awarded 80,000,000 warrants, exercisable at 4p each for a term of 5 years.
Reinstatement of Previous Share Subscription Facility
Under the terms of the CLNF, GEM is reinstating the prior
Further information regarding the SSF is set out in the Company's announcement on
Use of Proceeds
Proceeds of the CLNF will be used by the Company to finalise the audit for the FY 2024, effect the re-trading of its shares on the
Proceeds of the SSF will be used to finance growth and development of the Company.
About Global Emerging Markets (GEM)
Certain information contained in this announcement would have been inside information for the purposes of Article 7 of Regulation No 596/2014 (as it forms part of
For further information, please contact:
|
|
|
+44 (0)20 3821 6167 |
Flagstaff Strategic and Investor
|
+44 (0)20 7129 1474 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the